Company news

Orion Oyj news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

CHMP recommends third indication for darolutamide for patients with advanced prostate cancer

June 20, 2025

Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs

June 17, 2025

U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer

June 3, 2025

Orion announces agreement with Shilpa Medicare for Recombinant Human Albumin for European market

May 23, 2025

Orion to host Capital Markets Day today, 22 May 2025, in Helsinki

May 22, 2025

Orion’s collaborator, MSD, expands clinical development program for opevesostat to women’s cancers

May 21, 2025

Orion Corporation: Managers’ transactions – Veli-Matti Mattila

May 2, 2025

Orion Corporation: Managers’ transactions – Maziar Mike Doustdar

May 2, 2025

Orion Corporation: Managers’ transactions – Kari Jussi Aho

May 2, 2025

Orion Corporation: Managers’ transactions – Karen Lykke Sørensen

May 2, 2025

Orion Corporation: Managers’ transactions – Hilpi Rautelin

May 2, 2025

Orion Corporation: Managers’ transactions – Henrik Stenqvist

May 2, 2025

Orion Corporation: Managers’ transactions – Eija Ronkainen

May 2, 2025

Orion Corporation: Managers’ transactions – Ari Lehtoranta

May 2, 2025

301,521 Orion Corporation A shares converted into B shares

May 2, 2025

Orion and Criceto Announce a License Agreement for APORON®, an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson’s Disease

April 25, 2025

Composition of the Nomination Committee of Orion Corporation

April 24, 2025

Orion Group Interim Report January–March 2025

April 23, 2025

Invitation to Orion’s Capital Markets Day on 22 May 2025

April 22, 2025

← Newer news releases

Calls

The 5 newest of 14 calls. Every call is listed under its year.

Decks

The 5 newest of 224 decks. Every deck is listed under its year.